You are here Home Resources and guidance Sponsors Mayne Pharma International Pty Ltd Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type ARTG (5) Cancellation by sponsor (5) Australian public assessment report (AusPar) (1) Date (-) 2022 (11) 2025 (5) 2024 (3) 2023 (14) 2021 (5) 2020 (9) 2019 (4) 2018 (13) 2017 (7) 2015 (2) 2014 (3) 2013 (3) 2012 (4) 2010 (1) 2009 (1) 2007 (1) 2004 (2) 2002 (1) 1999 (1) 1998 (1) 1996 (6) 1994 (3) 1991 (10) Search Filters applied:2022Clear all Sponsor content11 result(s) found, displaying 11 to 11 AusPAR: Nextstellis 11 August 2022 Australian public assessment report (AusPar) Nextstellis (estetrol monohydrate and drospirenone) for the prevention of pregnancy Pages First page « First Previous page ‹ Previous Page 1 Current page 2
AusPAR: Nextstellis 11 August 2022 Australian public assessment report (AusPar) Nextstellis (estetrol monohydrate and drospirenone) for the prevention of pregnancy